Physician profile
Dieter H Eppel
NPI 1710932934
$1,431.58
in general payments reported to CMS, 2019-2025
23 companies · $746 in 2025
The $746 reported for 2025 was more than what 87% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.71 · 2020: $20.65 · 2023: $181 · 2024: $420 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,347.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $254.37 | 2023-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $139.71 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $121.57 | 2025 | Airsupra, Breztri |
| Otsuka America Pharmaceutical, INC. | $100.76 | 2025 | Rexulti |
| Exact Sciences Corporation | $92.87 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $87.08 | 2019-2025 | Pediarix, Bexsero, Rotarix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.85 | 2023-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $71.27 | 2023-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $67.91 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $52.56 | 2025 | Zoryve |
| Bayer Healthcare Pharmaceuticals INC. | $50.80 | 2024 | |
| Corcept Therapeutics | $46.02 | 2025 | Korlym |
| Medtronic, INC. | $42.58 | 2024-2025 | Intellis Adaptivestim |
| Lundbeck LLC | $40.08 | 2025 | Rexulti |
| Edwards Lifesciences Corporation | $31.23 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $28.59 | 2024 | Repatha, Otezla |
| Viatris Specialty LLC | $27.00 | 2025 | Yupelri |
| Hologic Sales and Service, LLC | $20.02 | 2023 | Thinprep 2000 Processor, Aptima |
| Xeris Pharmaceuticals, INC. | $19.37 | 2025 | Gvoke Hypopen |
| Vertex Pharmaceuticals Incorporated | $17.18 | 2025 | |
| Mylan Specialty L.P. | $16.54 | 2024 | Yupelri |
| Esperion Therapeutics, INC. | $16.43 | 2025 | Nexletol |
| Inspire Medical Systems, INC. | $15.79 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dieter Eppel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.